Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Gastroenterology
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib
Masayuki Sarutaa Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-8172-3240View further author information
https://orcid.org/0000-0001-8172-3240View further author information, Isao Kawaguchib AbbVie GK, Tokyo, Japanhttps://orcid.org/0000-0002-0993-9466View further author information
https://orcid.org/0000-0002-0993-9466View further author information, Yuji Ogawab AbbVie GK, Tokyo, Japanhttps://orcid.org/0009-0009-4949-4260View further author information
https://orcid.org/0009-0009-4949-4260View further author information, Yuri Sanchez Gonzalezc AbbVie Inc., North Chicago, IL, USAhttps://orcid.org/0000-0001-7261-1933View further author information
https://orcid.org/0000-0001-7261-1933View further author information, Naoki Numajirib AbbVie GK, Tokyo, Japanhttps://orcid.org/0009-0007-9873-721XView further author information
https://orcid.org/0009-0007-9873-721XView further author information, Xiaohe Tangd Syneos Health, Tokyo, Japanhttps://orcid.org/0000-0002-4873-6688View further author information
https://orcid.org/0000-0002-4873-6688View further author information & Russell Millerd Syneos Health, Tokyo, Japanhttps://orcid.org/0000-0002-0990-0908View further author information
https://orcid.org/0000-0002-0990-0908View further author information show all